⌘K
Loading ticker…
As of 2026-08-24, Fate Therapeutics, Inc. (FATE) has a 3-month relative strength percentile of 64 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 70. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.6%, relative volume 0.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
FATE is held by 13 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $4M.
Held by 25 ETFs · $14M across latest filings · largest weight 0.78% (QQQS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $1M | — |
| VHTVanguard Health Care ETF | 0.00% | $831K | — |
| VTWV | 0.02% | $236K | — |
| QQQS | 0.78% | $147K | +0.17 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $115K |
| new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $23K | — |
| ITWO | 0.01% | $15K | — |
| MSSM | 0.00% | $12K | — |
| URTY | 0.00% | $11K | — |
Showing 10 of 13 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FATE Jan avg: 5.92% median: -0.05% win: 50% σ: 46.97% n: 4 2022-04-12 → 2026-07-31 | FATE Feb avg: 7.08% median: 8.89% win: 75% σ: 16.54% n: 4 2022-04-12 → 2026-07-31 | FATE Mar avg: -12.93% median: -12.89% win: 25% σ: 14.34% n: 4 2022-04-12 → 2026-07-31 | FATE Apr avg: 1.24% median: 4.17% win: 60% σ: 40.13% n: 5 2022-04-12 → 2026-07-31 | FATE May avg: 15.79% median: -6.83% win: 20% σ: 62.56% n: 5 2022-04-12 → 2026-07-31 | FATE Jun avg: -4.34% median: -5.74% win: 20% σ: 6.88% n: 5 2022-04-12 → 2026-07-31 | FATE Jul avg: 12.29% median: -1.79% win: 40% σ: 31.44% n: 5 2022-04-12 → 2026-07-31 | FATE Aug avg: -22.55% median: -22.76% win: 0% σ: 15.39% n: 4 2022-04-12 → 2026-07-31 (current) | FATE Sep avg: -3.32% median: -9.45% win: 25% σ: 17.03% n: 4 2022-04-12 → 2026-07-31 | FATE Oct avg: -11.60% median: -10.64% win: 25% σ: 16.46% n: 4 2022-04-12 → 2026-07-31 | FATE Nov avg: 13.82% median: 16.64% win: 50% σ: 26.00% n: 4 2022-04-12 → 2026-07-31 | FATE Dec avg: -15.77% median: -30.88% win: 25% σ: 47.16% n: 4 2022-04-12 → 2026-07-31 |